Literature DB >> 19040475

Genetic background of Escherichia coli isolates from patients with spontaneous bacterial peritonitis: relationship with host factors and prognosis.

F Bert1, X Panhard, J Johnson, H Lecuyer, R Moreau, J Le Grand, B Johnston, M Sinègre, D Valla, M-H Nicolas-Chanoine.   

Abstract

Spontaneous bacterial peritonitis (SBP) is a severe complication in patients with cirrhosis and ascites. It is predominantly caused by Escherichia coli. The phylogenetic group and virulence genotype of E. coli isolates causing SBP were investigated, and the association of these characteristics with host factors and prognosis was examined. Seventy-six episodes of E. coli SBP that occurred over a 9-year period were studied. The phylogenetic group of the isolates and the presence of 36 virulence factor genes were investigated. The influence of bacterial and host factors on in-hospital mortality was assessed by multiple logistic regression. Phylogenetic groups A, B1, B2 and D were found in 26%, 4%, 46% and 24% of the isolates, respectively. Virulence factor genes were more frequent in B2 isolates than in non-B2 isolates (mean virulence score 15.4 vs. 7.3, p <10(-4)). Ciprofloxacin resistance was significantly associated with non-B2 groups and a low virulence score. Host factors independently associated with a shift from B2 to non-B2 isolates were norfloxacin prophylaxis (OR 13.01, p 0.0213) and prothrombin ratio (OR 1.04 for a 10% decrease, p 0.0211). The model for end-stage liver disease (MELD) score (OR 1.83, p 0.0007) and hospital-acquired SBP (OR 4.13, p 0.0247) were independent predictors of in-hospital mortality. In contrast, outcome was not influenced by the phylogenetic group or the virulence profile. These findings indicate that the characteristics of E. coli isolates causing SBP vary with the severity of liver disease and with fluoroquinolone prophylaxis. Host factors are more important than bacterial factors in predicting in-hospital mortality.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19040475     DOI: 10.1111/j.1469-0691.2008.02088.x

Source DB:  PubMed          Journal:  Clin Microbiol Infect        ISSN: 1198-743X            Impact factor:   8.067


  10 in total

1.  Role of K1 capsule antigen in cirrhotic patients with Escherichia coli spontaneous bacterial peritonitis in southern Taiwan.

Authors:  M C Wang; W H Lin; C C Tseng; A B Wu; C H Teng; J J Yan; J J Wu
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2012-10-08       Impact factor: 3.267

2.  Renal dysfunction is the most important independent predictor of mortality in cirrhotic patients with spontaneous bacterial peritonitis.

Authors:  Puneeta Tandon; Guadalupe Garcia-Tsao
Journal:  Clin Gastroenterol Hepatol       Date:  2010-12-08       Impact factor: 11.382

3.  Genetic diversity and virulence profiles of Escherichia coli isolates causing spontaneous bacterial peritonitis and bacteremia in patients with cirrhosis.

Authors:  Frédéric Bert; James R Johnson; Bénédicte Ouattara; Véronique Leflon-Guibout; Brian Johnston; Estelle Marcon; Dominique Valla; Richard Moreau; Marie-Hélène Nicolas-Chanoine
Journal:  J Clin Microbiol       Date:  2010-06-02       Impact factor: 5.948

4.  Host Characteristics and Bacterial Traits Predict Experimental Virulence for Escherichia coli Bloodstream Isolates From Patients With Urosepsis.

Authors:  James R Johnson; Stephen Porter; Brian Johnston; Michael A Kuskowski; Rachel R Spurbeck; Harry L T Mobley; Deborah A Williamson
Journal:  Open Forum Infect Dis       Date:  2015-06-06       Impact factor: 3.835

5.  Major differences exist in frequencies of virulence factors and multidrug resistance between community and nosocomial Escherichia coli bloodstream isolates.

Authors:  Niamh M Cooke; Stephen G Smith; Mary Kelleher; Thomas R Rogers
Journal:  J Clin Microbiol       Date:  2010-01-27       Impact factor: 5.948

6.  Production of HlyA and ClyA haemolysins among quinolone-resistant Escherichia coli isolated from clinical samples.

Authors:  Alicia Márquez-López; Belén Ruiz Del Castillo; María Eliecer Cano; Cristina Rodríguez-Mirones; Jesús Oteo; David Sáez; Luis Martínez-Martínez
Journal:  Springerplus       Date:  2013-02-27

7.  Prevention and management of bacterial infections in cirrhosis.

Authors:  Sunil K Taneja; Radha K Dhiman
Journal:  Int J Hepatol       Date:  2011-08-28

Review 8.  When to use antibiotics in the cirrhotic patient? The evidence base.

Authors:  Jiannis Anastasiou; Roger Williams
Journal:  Ann Gastroenterol       Date:  2013

Review 9.  Evaluation of the health and healthcare system burden due to antimicrobial-resistant Escherichia coli infections in humans: a systematic review and meta-analysis.

Authors:  M C MacKinnon; J M Sargeant; D L Pearl; R J Reid-Smith; C A Carson; E J Parmley; S A McEwen
Journal:  Antimicrob Resist Infect Control       Date:  2020-12-10       Impact factor: 4.887

10.  Use of the delta neutrophil index as a prognostic factor of mortality in patients with spontaneous bacterial peritonitis: implications of a simple and useful marker.

Authors:  Tae Seop Lim; Beom Kyung Kim; Jong Wook Lee; Young Ki Lee; Sooyun Chang; Seung Up Kim; Do Young Kim; Sang Hoon Ahn; Kwang-Hyub Han; Chae Yoon Chon; Jun Yong Park
Journal:  PLoS One       Date:  2014-01-23       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.